Corrigendum to "Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study".

Vernooij, R W M; Cremers, R G H M; Jansen, H; Somford, D M; Kiemeney, L A; van Andel, G; Wijsman, B P; Busstra, M B; van Moorselaar, R J A; Wijnen, E M; Pos, F J; Hulshof, M C C M; Hamberg, P; van den Berkmortel, F; Hulsbergen-van de Kaa, C A; van Leenders, G J L H; Fütterer, J J; van Oort, I M; Aben, K K H

Vernooij, R W M; Cremers, R G H M; Jansen, H; Somford, D M; Kiemeney, L A; van Andel, G; Wijsman, B P; Busstra, M B; van Moorselaar, R J A; Wijnen, E M; Pos, F J; Hulshof, M C C M; Hamberg, P; van den Berkmortel, F; Hulsbergen-van de Kaa, C A; van Leenders, G J L H; Fütterer, J J; van Oort, I M; Aben, K K H.

Afiliação

Vernooij RWM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Cremers RGHM; Department of Urology, Deventer Hospital, Deventer, the Netherlands.
Jansen H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Kiemeney LA; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
Wijsman BP; Department of Urology, Elisabeth-TweeSteden hospital, Tilburg, the Netherlands.
Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Wijnen EM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Pos FJ; Department of Radiotherapy, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
van den Berkmortel F; Department of Oncology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Laboratory for Pathology East Netherlands, Hengelo, the Netherlands.
van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Fütterer JJ; Department of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands>.
van Oort IM; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: k.aben@iknl.nl.

Urol Oncol ; 40(7): 353, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35654644

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google